COMP <GO>
ADUS vs JNJ // DIVIDEND YIELD & FCF PAYOUT SAFETY
Addus HomeCare Corporation (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ADUS 7
— JNJ 5
■ METRIC PARITY
LAST: $124.34 (+1.77%) • MKT CAP: $2.32B
dividend-safety
0.00%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ADUS VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ADUS | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | 67.90% | -35.40 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.10% | 25.50% | -16.40 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.8x | 18.5x | -1.70 | ADUS | /valuation <GO> |
| Free Cash Flow Yield | 4.47% | 2.97% | +1.50 | ADUS | /fcf-yield <GO> |
| Operating Margin | 9.70% | 34.70% | -25.00 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 6.70% | 28.50% | -21.80 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 23.20% | 6.00% | +17.20 | ADUS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 5.59 | +0.24 | ADUS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | ADUS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.8 | 62.1 | +5.70 | ADUS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.3x | 23.0x | -2.70 | ADUS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.32B | $662.49B | -$660.17B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ADUS REV | JNJ REV | ADUS GROSS % | JNJ GROSS % | ADUS FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.42B | $94.19B | 32.5% | 67.9% | $103.8M | $19.70B |
| FY 2024 | $1.15B | $88.82B | 32.5% | 69.1% | $110.4M | $19.84B |
| FY 2023 | $1.06B | $85.16B | — | — | $112.2M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ADUS // BETA —
JNJ // BETA 1.08